Results 1 to 10 of about 25,086 (140)

Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible

Indian Pacing and Electrophysiology Journal, 2023
Implantation of subcutaneous implantable cardioverter-defibrillator in a patient with existing unipolar pacemaker is against manufacturer recommendations. We report the case of a successful subcutaneous implantable cardioverter-defibrillator implantation
Matanyahu Rubinstein, Angela Zhu, Justin A. Mariani, Hitesh C. Patel   +3 more
doaj   +1 more source

Implantable cardioverter defibrillators [PDF]

Clinical Medicine, 2007
Sudden cardiac death occurs in 70,000-100,000 people annually in the UK, mostly in people with pre-existing heart disease but in 20% it is the first presentation Previous myocardial infarction (Ml) and significant left ventricular dysfunction are associated with a high rate of sudden cardiac death Implantable defibrillators are recommended in the ...
Stuart, Harris, Mehul, Dhinoja
openaire   +2 more sources

Surface mapping demonstrates compatibility of implantable loop monitor with a continuous‐flow left ventricular assist device

ESC Heart Failure, 2021
Syncope in patients with continuous‐flow left ventricular assist device may be associated with arrhythmia and difficult to determine without an implantable cardioverter defibrillator.
Angela Li, Gourg Atteya, Sirish Vullaganti, Ramanak Mitra   +3 more
doaj   +1 more source

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child [PDF]

Acute and Critical Care, 2021
Pediatric cardiac tumors are rare. Among these, cardiac fibroma is the second most common. Its clinical manifestations depend on size and location of the tumor and include arrhythmia or obstruction to blood flow.
In Su Choi, Hyung Ki Jeong, Hyung Wook Park, Yi-Seul Kim   +3 more
doaj   +1 more source

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. [PDF]

PLoS ONE, 2018
Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation.We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis ...
Dirk Skowasch, Steven Ringquist, Georg Nickenig, René Andrié   +3 more
doaj   +1 more source

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background One third of primary prevention implantable cardioverter‐defibrillator patients receive appropriate therapy, but all remain at risk of defibrillator complications. Information on these complications in contemporary cohorts is limited.
Marit van Barreveld, Tom E. Verstraelen, Pascal F. H. M. van Dessel, Lucas V. A. Boersma, Peter Paul H. M. Delnoy, Anton E. Tuinenburg, Dominic A. M. J. Theuns, Pepijn H. van der Voort, Geert‐Jan Kimman, Erik Buskens, Aeilko H. Zwinderman, Arthur A. M. Wilde, Marcel G. W. Dijkgraaf   +12 more
doaj   +1 more source

Pacemakers and implantable cardioverter defibrillators – general and anesthetic considerations

Brazilian Journal of Anesthesiology, 2014
A pacemaking system consists of an impulse generator and lead or leads to carry the electrical impulse to the patient's heart. Pacemaker and implantable cardioverter defibrillator codes were made to describe the type of pacemaker or implantable ...
Amy G. Rapsang, Prithwis Bhattacharyya
doaj   +3 more sources

Editorial: Developments in cardiac implantable electronic device therapy: how can we improve clinical implementation?

Frontiers in Cardiovascular Medicine, 2023
GRAPHICAL ABSTRACTCIED, cardiac implantable electronic devices; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy defibrillator; EA, electroanatomical; ICD, implantable cardioverter defibrillator; LBB, left bundle branch ...
Mate Vamos, Julia W. Erath, Alexander P. Benz, Alexander P. Benz, Gabor Z. Duray   +4 more
doaj   +1 more source

Subcutaneous Implantable Cardioverter Defibrillator [PDF]

Circulation: Arrhythmia and Electrophysiology, 2012
Implantable cardioverter-defibrillators (ICDs) represent a very effective therapy for primary and secondary prevention of sudden cardiac death (SCD). However, implantation of endocardial leads using a transvenous approach is associated with significant procedural and long term complications.
Christopher P, Rowley, Michael R, Gold
openaire   +2 more sources

Implantable cardioverter-defibrillator utilization [PDF]

Europace, 2011
Following the recent publication of our article1 concerning the European paradox with regard to implantable cardioverter defibrillator (ICD) device utilization in Europe (markedly lower device utilization in Europe compared with the USA), which updated several previous reports,2,3 …
John, Camm, Seah, Nisam
openaire   +2 more sources